Streamline Health Solutions (STRM) Stock
Publicly traded company. Here's the price, business snapshot, and what's worth knowing about Streamline Health Solutions in June 2026.
Streamline Health Solutions, Inc. enables healthcare organizations to proactively address revenue leakage and improve financial performance. The Company delivers integrated solutions, technology-enabled services and analytics. It operates in one segment as a provider of health information technology solutions and associated services that improve healthcare processes and information flows within a healthcare facility. It sells its solutions and services in North America to hospitals and health systems through its direct sales force and its reseller partnerships. It offers solutions and services to assist its clients in revenue cycle management, including its two flagship technologies: RevID and eValuator. RevID offers automated, daily reconciliation of clinical event activity to patient billing charge items prior to billing. eValuator provides 100% automated coding analysis prior to billing. In addition, it offers an array of professional services, including system implementation.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Streamline Health Solutions stock, with a target price of $22.5.
Financial Health
Streamline Health Solutions is successfully generating revenue and cash flow, with healthy profit margins.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring STRM
Corporate Efficiency Stocks | Amazon Layoff Impact
Amazon is undertaking its largest corporate layoff in decades, driven by a strategic push to increase efficiency and reduce bureaucracy. This corporate overhaul spotlights an investment opportunity in companies that provide automation and operational streamlining solutions.
Published: January 23, 2026
Explore BasketHealthcare's Compliance Catalyst
The Department of Justice's investigation into UnitedHealth's billing practices is increasing pressure on the entire healthcare industry to ensure compliance. This regulatory focus creates an investment opportunity in companies that provide specialized technology for transparent and accurate medical billing.
Published: July 26, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.